Compile Data Set for Download or QSAR
Report error Found 218 Enz. Inhib. hit(s) with all data for entry = 10130
TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515380(US11098061, Compound I-3)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515381(US11098061, Compound I-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515384(US11098061, Compound I-7)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515385(US11098061, Compound I-9)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515386(US11098061, Compound I-10)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515387(US11098061, Compound I-23)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515389(US11098061, Compound II-1)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515389(US11098061, Compound II-1)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515379(US11098061, Compound I-8)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515399(US11098061, Compound II-11)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515399(US11098061, Compound II-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515400(US11098061, Compound II-12)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515401(US11098061, Compound II-13)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515402(US11098061, Compound II-14)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515402(US11098061, Compound II-14)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515403(US11098061, Compound II-15)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515403(US11098061, Compound II-15)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515404(US11098061, Compound II-16)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515404(US11098061, Compound II-16)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515405(US11098061, Compound II-19 | US11098061, Compound ...)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515406(US11098061, Compound II-18)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515405(US11098061, Compound II-19 | US11098061, Compound ...)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515390(US11098061, Compound II-2)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515390(US11098061, Compound II-2)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515391(US11098061, Compound II-3)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515391(US11098061, Compound II-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515392(US11098061, Compound II-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515392(US11098061, Compound II-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515393(US11098061, Compound II-5)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515393(US11098061, Compound II-5)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515394(US11098061, Compound II-6)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515394(US11098061, Compound II-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515396(US11098061, Compound II-8)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515396(US11098061, Compound II-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515397(US11098061, Compound II-9)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515398(US11098061, Compound II-10)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515419(US11098061, Compound III-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515420(US11098061, Compound III-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515420(US11098061, Compound III-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515421(US11098061, Compound III-5)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515422(US11098061, Compound III-6)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515422(US11098061, Compound III-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515423(US11098061, Compound III-7)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515424(US11098061, Compound III-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515427(US11098061, Compound III-11)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515427(US11098061, Compound III-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515408(US11098061, Compound II-20)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515409(US11098061, Compound II-21)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515410(US11098061, Compound II-22)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM515411(US11098061, Compound II-23)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 218 total ) | Next | Last >>
Jump to: